Xiaojian Han

Chongqing Key Laboratory Of Tumor Immune Regulation And Immune Intervention
Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Therapeutic potential of T-cell receptor targeting the HLA-A*11:01-restricted KRASG12V neoantigen without cross-recognition of the self-antigen RAB7B in solid tumors.

Therapeutic potential of T-cell receptor targeting the HLA-A*11:01-restricted KRASG12V neoantigen without cross-recognition of the self-antigen RAB7B in solid tumors.

Journal: Journal for immunotherapy of cancer

Published: July 02, 2025

Functional avidity enhancement of a T-cell receptor targeting the KRASG12D cancer neoantigen.

Functional avidity enhancement of a T-cell receptor targeting the KRASG12D cancer neoantigen.

Journal: Cellular immunology

Published: April 01, 2025

PCK1 deficiency promotes MASH-HCC progression by 12-HETE-induced CD8+ T cell dysfunction.

PCK1 deficiency promotes MASH-HCC progression by 12-HETE-induced CD8+ T cell dysfunction.

Journal: Gut

Published: December 10, 2024

Identification of novel KRASG12D neoantigen specific TCRs and a strategy to eliminate off-target recognition.

Identification of novel KRASG12D neoantigen specific TCRs and a strategy to eliminate off-target recognition.

Journal: Journal of translational medicine

Published: October 08, 2024

Multidimensional evaluation of CMV-specific T Cells: enhancing therapy through transcriptional insights.

Multidimensional evaluation of CMV-specific T Cells: enhancing therapy through transcriptional insights.

Journal: Current research in translational medicine

Published: October 02, 2024

Cbl-b inhibition promotes less differentiated phenotypes of T cells with enhanced cytokine production.

Cbl-b inhibition promotes less differentiated phenotypes of T cells with enhanced cytokine production.

Journal: Cellular immunology

Published: July 05, 2024

Targeting tumor-infiltrating CCR8+ regulatory T cells induces antitumor immunity through functional restoration of CD4+ Tconvs and CD8+ T cells in colorectal cancer.

Targeting tumor-infiltrating CCR8+ regulatory T cells induces antitumor immunity through functional restoration of CD4+ Tconvs and CD8+ T cells in colorectal cancer.

Journal: Journal of translational medicine

Published: May 12, 2024

Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutations.

Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutations.

Journal: Cancer immunology, immunotherapy : CII

Published: April 10, 2024

Prophylactic efficacy of an intranasal spray with 2 synergetic antibodies neutralizing Omicron.

Prophylactic efficacy of an intranasal spray with 2 synergetic antibodies neutralizing Omicron.

Journal: JCI insight

Published: April 05, 2023

Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium.

Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium.

Journal: Cell reports

Published: October 17, 2022

Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy.

Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy.

Journal: Annals of medicine

Published: October 04, 2022

Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection.

Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection.

Journal: Frontiers in medicine

Published: June 16, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026